We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$9.61B
AUM Growth
+$620M
Cap. Flow
+$78.9M
Cap. Flow %
0.82%
Top 10 Hldgs %
26.27%
Holding
1,380
New
183
Increased
256
Reduced
860
Closed
74
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
101
Applied Materials
AMAT
$435B
$19.2M 0.2%
132,756
-115
-0.1% -$14.4K
PLD icon
102
Prologis
PLD
$134B
$18.9M 0.2%
154,170
-2,669
-2% -$328K
MMP
103
DELISTED
Magellan Midstream Partners, L.P.
MMP
$18.9M 0.2%
+302,624
New +$17.7M
AMGN icon
104
Amgen
AMGN
$225B
$18.8M 0.2%
84,628
-38
-0% -$8.82K
ISRG icon
105
Intuitive Surgical
ISRG
$142B
$18.7M 0.19%
54,783
-180
-0.3% -$54.5K
COP icon
106
ConocoPhillips
COP
$153B
$18.3M 0.19%
176,613
-2,086
-1% -$214K
DE icon
107
Deere & Co
DE
$167B
$18.2M 0.19%
45,023
-4,490
-9% -$1.72M
TJX icon
108
TJX Companies
TJX
$169B
$18.2M 0.19%
214,258
-1,324
-0.6% -$104K
PDCE
109
DELISTED
PDC Energy, Inc.
PDCE
$18.1M 0.19%
+254,824
New +$17.2M
ADI icon
110
Analog Devices
ADI
$187B
$18.1M 0.19%
92,978
-2,154
-2% -$399K
CAT icon
111
Caterpillar
CAT
$393B
$18.1M 0.19%
73,432
-566
-0.8% -$126K
NOW icon
112
ServiceNow
NOW
$129B
$18M 0.19%
159,935
-180
-0.1% -$18K
GS icon
113
Goldman Sachs
GS
$302B
$17.9M 0.19%
55,425
-1,352
-2% -$444K
GILD icon
114
Gilead Sciences
GILD
$168B
$17.7M 0.18%
230,194
-2,297
-1% -$183K
UNP icon
115
Union Pacific
UNP
$174B
$17.7M 0.18%
86,637
-9,576
-10% -$1.9M
LMT icon
116
Lockheed Martin
LMT
$140B
$17.4M 0.18%
37,814
-263
-0.7% -$122K
VRTX icon
117
Vertex Pharmaceuticals
VRTX
$133B
$17.3M 0.18%
49,195
-235
-0.5% -$79.2K
MDLZ icon
118
Mondelez International
MDLZ
$79.4B
$17.2M 0.18%
236,034
-2,586
-1% -$191K
GE icon
119
GE Aerospace
GE
$379B
$17.1M 0.18%
195,012
+351
+0.2% +$28.4K
BA icon
120
Boeing
BA
$183B
$17.1M 0.18%
80,781
+413
+0.5% +$85.8K
MDT icon
121
Medtronic
MDT
$116B
$16.9M 0.18%
191,917
+1,323
+0.7% +$114K
IJR icon
122
iShares Core S&P Small-Cap ETF
IJR
$112B
$16.9M 0.18%
169,388
+30,034
+22% +$2.86M
SYNH
123
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$16.5M 0.17%
+390,877
New +$15.8M
CVS icon
124
CVS Health
CVS
$121B
$16.3M 0.17%
236,497
+17,951
+8% +$1.28M
AXP icon
125
American Express
AXP
$232B
$16.3M 0.17%
93,356
+30
+0% +$4.84K

Similar funds

New York Life Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, New York Life Investment Management held 1,380 positions worth $9.61B, up 6.9% from $8.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

New York Life Investment Management's Q2 2023 filing shows 183 new, 256 increased, 860 reduced and 74 closed positions. Its largest new stake was JPMorgan Equity Premium Income ETF: 826,750 shares worth $45.7M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • New York Life Investment Management's largest Q2 2023 buy was JPMorgan Equity Premium Income ETF: 826,750 shares worth $45.7M.
  • New York Life Investment Management added most to iShares Floating Rate Bond ETF in Q2 2023, an estimated $136M increase.
  • New York Life Investment Management's biggest Q2 2023 reduction was IQ Candriam US Large Cap Equity ETF, cutting an estimated $35.8M.
  • New York Life Investment Management fully exited Vanguard Short-Term Corporate Bond ETF in Q2 2023, selling an estimated $108M.
  • New York Life Investment Management's ten largest holdings make up 26% of its $9.61B portfolio in Q2 2023.
  • New York Life Investment Management opened 183 new positions and closed 74 in Q2 2023.
  • New York Life Investment Management's portfolio value rose 6.9% quarter-over-quarter to $9.61B.

Based on New York Life Investment Management's 13F filing for Q2 2023, filed 7 Aug 2023.